Stent thrombosis and restenosis associated with the commonly used drug-eluting stents (DES) [Cypher Select vs. Xience Xpedition vs. Resolute Integrity] in patients with stable angina, STEMI/NSTEMI: Data from SCAAR registry

Trial Profile

Stent thrombosis and restenosis associated with the commonly used drug-eluting stents (DES) [Cypher Select vs. Xience Xpedition vs. Resolute Integrity] in patients with stable angina, STEMI/NSTEMI: Data from SCAAR registry

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Everolimus (Primary) ; Sirolimus (Primary) ; Zotarolimus (Primary)
  • Indications Angina pectoris; Myocardial infarction
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top